Standardization of the pathologic diagnosis of appendiceal mucinous neoplasms.

Non-mucinous adenocarcinoma is less common than mucinous adenocarcinoma [ 1 ]. Uemura et al. [ 54 ] reported that nonmucinous adenocarcinoma is biologically distinct from the mucinous subtype and shows mostly moderate to poorly differentiated with frequent peritoneal metastasis. The histopathologic findings and tumor grading of non-mucinous adenocarcinoma are the same as conventional colorectal adenocarcinoma [ 1 ]. Non-mucinous adenocarcinoma demonstrates a high level of MSI. The frequency of KRAS mutation is similar in both colorectal adenocarcinomas and appendiceal non-mucinous adenocarcinomas, but the molecular pathogenesis is different [ 38 , 55 , 56 ]. The PSOGI panel prefers to confine “adenoma” to lesions that resemble conventional adenomas of the colorectum limited to the mucosa and intact muscularis mucosae without luminal dilatation or expansile growth pattern [ 12 , 23 ]. Based on this, appendiceal adenomas are uncommon, and many neoplasms that were previously reported as adenomas are now classified as LAMN or serrated lesions. For example, a villous lesion showing serration with conventional dysplasia and intact muscularis mucosae without pushing invasion should be called a serrated dysplasia rather than a villous adenoma. The WHO 5th Digestive System Tumors and CAP protocol recommend that appendiceal adenoma should be restricted to the precursor lesion of non-mucinous adenocarcinoma [ 1 , 14 , 22 ]. The histologic findings of non-mucinous adenocarcinoma arising in adenoma are presented in Fig. 9A – C . Goblet cell adenocarcinoma can occur almost exclusively in the appendix and is sometimes difficult to differentiate from AMNs and non-mucinous appendiceal tumors. Goblet cell adenocarcinoma, previously called goblet cell carcinoid or mucinous carcinoid, is a rare and aggressive tumor [ 1 ]. The tumor components are goblet-like cells and variable numbers of neuroendocrine cells and Paneth-like cells, and it is characteristically arranged as tubules similar to intestinal crypts [ 1 ]. The classic low-grade tumor displays tubular or clustered growth and small groups of cohesive goblet cells, whereas the high-grade tumor shows infiltrating tumor cells, convoluted anastomosing tubules, cribriform masses, irregular solid pattern, and large aggregates of goblet cells or signet-ring cells [ 57 ]. Nonaka et al. [ 58 ] found that neuroendocrine cells are inconsistent and not essential in the tumor component. For this reason, pathologists must find at least a focal lesion of classical low-grade tumor component to diagnose as a goblet cell adenocarcinoma. Several classification and grading systems have been described. Tang et al. [ 59 ] classified goblet cell adenocarcinomas into three groups based on the histopathologic features: group A (typical goblet cell carcinoid), group B (adenocarcinoma ex-goblet cell carcinoid, signet-ring cell type), and group C (adenocarcinoma ex-goblet cell carcinoid, poorly differentiated type). Recently, the WHO 5th Digestive System Tumors classified goblet cell adenocarcinomas into a three-tiered grading system, based on the proportion of the tumor cells that consists of low-grade and highgrade patterns as follows: grade 1, > 75% of low-grade pattern or < 25% of high-grade pattern; grade 2, 50%–75% of low-grade pattern or 25%–50% of high-grade pattern; and grade 3, 50% of the high-grade pattern [ 1 , 60 ]. Nonaka et al. [ 58 ] reported that the high-grade component percentage was correlated with cancer-specific survival. The histological and immunohistochemical findings of goblet cell adenocarcinoma are presented in Fig. 9D – F . The pathogenesis remains entirely elusive. It is generally believed that it is derived from the pluripotent stem cells at the crypt base that can undergo dual glandular and neuroendocrine differentiation.

The AJCC 7th Cancer Staging Manual was not clear on applying the staging criteria of AMNs [ 29 ]. However, the AJCC 8th Cancer Staging Manual showed significant changes to the staging criteria of AMNs, particularly for LAMN [ 13 ]. In addition, the role of acellular mucin or a mucinous epithelium outside of the appendix is also addressed and included in the staging [ 1 , 13 ]. A summary of the AJCC pT classification of LAMN and prognostic significance from the AJCC 8th Cancer Staging Manual is listed in Table 3 . In non-mucinous appendiceal tumors, the pTis category includes high-grade dysplasia, carcinoma in situ, and intramucosal carcinoma [ 13 ]. Notably, LAMNs confined to the appendiceal wall are classified as pTis. The staging of pTis reflects the excellent outcome when limited to the appendiceal wall [ 13 ]. In most LAMNs, there is no well-preserved mucosal architecture; hence, assessing the involvement of the mucosa and submucosa is impossible, resulting in the inability to apply pT1 designation to the LAMNs. In addition, studies evaluating the outcomes in LAMN have determined that pushing invasion into the appendiceal wall is not associated with tumor recurrence [ 7 , 11 , 30 ]. Thus, pT2 designation does not apply to LAMN [ 13 ]. Various pT stagings of LAMN were presented in the workshop and are illustrated in Fig. 6 . In a questionnaire for suspected pTis or other stages, many pathologists were unaware of the new concept of pTis(LAMN). Because mucinous tumors can frequently extend into the muscularis propria by pushing invasion in LAMN, mucin extending into the muscularis propria should be classified as pTis(LAMN) as long as it does not extend into the mesoappendix or serosa ( Fig. 6A , B ). LAMNs showing either acellular mucin or mucinous epithelium involvement to subserosa or mesoappendix are classified as pT3 ( Fig. 6C ). Perforation of the appendix by LAMN is associated with a high risk of peritoneal dissemination. Given the risk of disseminated peritoneal mucinous disease, pT4 includes assessing both acellular mucin and the mucinous epithelium and is designated as T4a (penetration of the serosa) ( Fig. 6D ) and T4b (directly invades adjacent organs or structures) ( Fig. 6E ). Notably, pT4a does not include luminal or mural spreading into the cecum. Most cases of LAMNs are associated with luminal mucin. This mucin can frequently contaminate the serosa during the gross examination, histologic processing, and even operation. These cases should not be diagnosed as pT4a. Indeed, mucinous deposits on the appendiceal serosa are associated with a granulation tissue-like response and neo-vascularization; numerous small capillaries containing red blood cells are seen coursing through the mucin ( Fig. 6F ). When the peritoneal dissemination is limited to acellular mucin only, it is classified as M1a. Other metastatic categories are M1b, which refers to metastases confined to the peritoneum only, and M1c which refers to metastases outside the peritoneum, such as pleuropulmonary metastasis. According to the Union for International Cancer Control staging system, LAMN and HAMN are considered as pTis, if confined to the appendiceal wall [ 1 ]. However, the AJCC 8th Cancer Staging Manual stated that the HAMN should be staged using the same staging system as invasive mucinous adenocarcinoma [ 13 ]. These two different opinions may bring confusion in daily practice. Valasek and Pai [ 3 ] proposed that HAMN with pushing invasion into the muscularis propria would be classified as pT2 using the same staging system for invasive adenocarcinoma. However, since there are very few cases of HAMN, the actual application of the staging for HAMNs will be determined after the results of large-scale survival analysis. We surveyed the expected pT stages of the HAMNs at the workshop, and the responses are shown in Supplementary Data S2 .

The WHO 5th Digestive System Tumors defined an appendiceal serrated lesion as a mucinous epithelial lesion characterized by a serrated (sawtooth or stellate) architecture of the luminal crypt [ 1 ]. Serrated lesions are classified as a hyperplastic polyp, sessile serrated lesion without dysplasia, and serrated lesion with dysplasia or serrated dysplasia [ 1 , 14 ]. Polyps that lack a luminal crypt of serrated architecture and dysplasia are classified as hyperplastic polyps. Sessile serrated lesions are commonly deficient in cytological dysplasia. They often involve mucosa in a diffuse circumferential fashion. Serrated dysplasia refers to conventional adenoma-like dysplasia, traditional serrated adenoma-like dysplasia, and mixed morphological patterns of dysplasia [ 14 ]. LAMNs are heterogeneous, with typical LAMN in some areas and serrated lesions in others, raising the possibility that some LAMNs could arise from serrated lesions. Occasionally, LAMNs simulate a serrated lesion and are challenging to diagnose, particularly if the muscularis mucosae is intact. By the diagnostic criteria of the PSOGI classification, a serrated lesion should be confined to the lesion with intact muscularis mucosae, no mucin in the wall or outside, and no expansile growth pattern or pushing invasion [ 12 ]. Although appendiceal serrated lesions have similar microscopic features to their colorectal counterparts, they commonly harbor KRAS mutations but lack BRAF mutations, indicating that the serrated pathway in the appendix is likely to be different from those of the colorectum [ 14 , 23 , 28 ]. However, serrated lesions remain incompletely studied and are not fully understood. The serrated lesions of the appendix are demonstrated in Fig. 5 .

The AJCC 8th Cancer Staging Manual defined a LAMN as a mucinous neoplasm with low-grade cytology associated with the obliteration of the muscularis mucosae without overt features of the invasion [ 13 ]. The lamina propria is frequently effaced, and mucosal lymphoid tissues are decreased or absent. Mucinous cystadenoma and mucocele were histologically used as synonyms for LAMN but are no longer recommended in pathologic reports due to their ambiguous and misleading nature. The essential histologic finding of LAMN is low-grade cytology with pushing invasion; however, there is no destructive invasion in the appendiceal wall. Fig. 1 demonstrates the microscopic features of LAMNs, displaying pushing invasion and broad-front spreading by a mucin-rich epithelium. Notably, when regarding whether pushing invasion is necessary for the diagnosis of LAMN, most of the survey responders diagnosed Fig. 1A , B as LAMN. In typical LAMNs, there is a loss of the normal mucosal architectures, at least focally, such as obliteration of the lamina propria and muscularis mucosa, fibrosis of the submucosa, and atrophy of the lymphoid follicles. Although the epithelium may show a papillary, villous, undulating, or flat architecture, lining epithelial cells are generally arranged in a monolayer ( Fig. 1C , D ). The microscopic features essential for LAMN proposed by the PSOGI panel are illustrated in Fig. 2 . It is not surprising that LAMN with intact muscularis mucosae may develop disseminated peritoneal mucinous disease. For this reason, there is hesitancy in diagnosing a lesion with intact muscularis mucosae as adenoma because adenomas should be limited to benign lesions that have no potential for peritoneal dissemination. Patients with LAMN often present symptoms like acute appendicitis. Typical LAMNs usually have thin fibrotic walls and abundant intraluminal mucin, and less commonly, calcification of the wall. Grossly apparent rupture with mucin extrusion is generally manifested in patients with disseminated peritoneal mucinous disease. Because LAMNs show benign-looking cytology, they can mimic several benign lesions associated with mucinous epithelial proliferation. The appendiceal diverticulum is perhaps the most common mimicker of LAMN due to their pushing growing pattern, specifically when related to abundant mucin exposed to the serosal surface. A preserved lamina propria is an indication of the diagnosis of a diverticulum. Careful examination of the entire appendix at lower magnification often leads to identifying a diverticulum. Sometimes, Schwann cell hyperplasia expands the lamina propria, possibly because of the obliteration effects [ 26 , 27 ]. If a histologic examination of the entire appendix fails to reveal a lining epithelium, the possibility of a retention cyst may be considered. Appendiceal retention cysts are rare and mostly small-sized; thus, lesions more than 2 cm in diameter are much more likely to be LAMNs. Appendiceal endometriosis with intestinal metaplasia is uncommon and can resemble a LAMN. The epithelial component acquires an intestinal phenotype characterized by columnar mucin-secreting cells, sometimes with goblet cells. Recognition of the endometrial stroma surrounding the glands and CD10 immunohistochemical stain will lead to a diagnosis. Mucosal hyperplasia can be seen in acute appendicitis. Mucosal hyperplasia tends to be more pronounced toward the luminal side and is frequently observed in areas of intense inflammation. Occasionally, reactive cellular atypia in the acute suppurative appendicitis may approximate the neoplastic atypia in LAMN. Fig. 3 reveals various mimickers of LAMN.

The GPSG-KSP presents a “Standardization of the Pathologic Diagnosis of the Appendiceal Mucinous Neoplasm.” This article focuses on the diagnostic criteria, terminology, grading, staging,biologic behaviors, treatment, and prognosis of AMNs and disseminated peritoneal mucinous disease. In addition, we propose a checklist of standard data elements of the appendiceal epithelial neoplasms. We hope that the present article will lead to the standardization of the pathologic diagnosis of AMNs and disseminated peritoneal mucinous disease and improvement in the communication between pathologists and between pathologists and clinicians.

HAMN was proposed for the lesion with similar architectures of LAMN having high-grade cytologic features but no infiltrative invasion [ 13 ]. Fig. 4 demonstrates the histologic findings of HAMN. The microscopic findings include cribriform, loss of nuclear polarity, high-grade cytology (i.e., enlarged, hyperchromatic, pleomorphic nuclei, and atypical mitotic figures), frequent single-cell necrosis and may present sloughing of necrotic cells into the lumen [ 23 ]. HAMNs are suggested to reveal an intermediate risk between LAMNs and mucinous adenocarcinomas. According to the WHO 5th Digestive System Tumors , the International Classification of Diseases for Oncology , 3rd edition (ICD-O3) behavior codes for LAMN and HAMN were proposed as 8480/1 and 8480/2, respectively ( Table 2 ). The response of the ICD-O3 of the HAMN was varied at the workshop because the questionnaire for the suspected ICD-O3 behavior code of the HAMN was conducted before the publication of the WHO 5th Digestive System Tumors . However, there was a consensus that the behavior code should be 8480/2 to avoid confusion in the following GPSG meeting. Misdraji et al. [ 7 ] reported that HAMNs show more aggressive clinical behavior than LAMNs, but the prognosis is still not unveiled because HAMNs are extremely rare. Therefore, nothing of the HAMNs prognosis is known. Yantiss et al. [ 11 ] reported that HAMN was more likely to be associated with aggressive clinical course and extra-appendiceal mucin spreading than LAMN. Carr et al. [ 23 ] proposed that HAMN should include lesions with high-grade cytologic atypia that is seen only focally, provided it is unequivocal; however, there has been no accepted consensus on the quantification of focal lesions yet. We surveyed the “focal” concept at the workshop, and the responses are shown in Supplementary Data S2 .

Appendiceal mucinous adenocarcinoma is defined as mucinous neoplasms showing infiltrative invasion comprised of > 50% extracellular mucin [ 1 ]. In contrast to the pushing invasion of the LAMN, the infiltrative invasion is confined to destructive stromal invasion into the appendiceal wall. The histologic features of infiltrative invasion include infiltrative tumor cells, which exhibit cribriform, small tubules, or single cells accompanied by mucin within the desmoplastic stroma, and small dissecting mucin containing floating tumor cells but inconspicuous desmoplastic reaction [ 1 , 3 , 12 ]. The neoplastic epithelium in mucinous adenocarcinoma demonstrates high-grade cytology that may be only seen focally, are characterized by enlarged nuclei, prominent nucleoli, increased mitotic figures, full-thickness stratification, and loss of nuclear polarity, which often extends to the luminal aspect of the epithelial cell. The PSOGI consensus panel has classified appendiceal mucinous adenocarcinomas and moderately and poorly differentiated mucinous adenocarcinoma, similar to the grading system of nonmucinous adenocarcinoma in other gastrointestinal tracts [ 12 ]. However, the PSOGI consensus classification was not easy to apply to appendiceal mucinous adenocarcinomas. The AJCC 8th Cancer Staging Manual classified the appendiceal mucinous tumors as a three-tier grading system: G1 (well-differentiated), G2 (moderately differentiated), and G3 (poorly differentiated), based on cytologic features, tumor cellularity, and signet-ring components [ 13 ]. Appendiceal G1 (well-differentiated) tumors are low-grade cytology, usually lacking infiltrative invasion, and essentially refers to LAMN. Given that mucinous adenocarcinoma is characterized by infiltrative invasion and almost always exhibits at least focal areas of high-grade cytologic features, typical mucinous adenocarcinomas should be classified as either G2 (moderately differentiated) or G3 (poorly differentiated) tumors [ 3 ]. Mucinous adenocarcinomas often show complex architecture, such as cribriform and complex papillary structures. The presence of signetring cells is an indication of infiltrative mucinous adenocarcinoma. Poorly differentiated (G3) mucinous adenocarcinoma demonstrates infiltrative invasion, with most having signet-ring cells. Signet-ring cells, characterized by prominent intracytoplasmic mucin displacing the nucleus, may infiltrate single cells or as aggregates, classified as grade G3 (poorly differentiated). Most G3 tumors are almost entirely composed of signet-ring cells, while a minority of cases are composed of mixed signet-ring cells and glandular structures. If cancer comprises ≤ 50% signet-ring cells, the WHO terminology is mucinous adenocarcinoma with signet-ring cells or mucinous adenocarcinoma, poorly differentiated. If the tumor contains > 50% signet-ring cells, the WHO terminology is signet-ring cell carcinoma. The microscopic findings of high-grade (G2 and G3) appendiceal mucinous adenocarcinomas are demonstrated in Fig. 7 . Most mucinous adenocarcinomas have clinically aggressive behavior, infiltrating through the appendiceal wall (pT4), and frequently metastasize to the abdominal or pelvic peritoneum at diagnosis. After an appendectomy specimen, diagnosis of mucinous adenocarcinoma should result in subsequent right hemicolectomy to evaluate lymph node metastases. A limited number of studies have reported that the vast majority of KRAS mutations occurred in G1 and G2 tumors [ 4 , 31 - 35 ], and most KRAS mutations occur in 50% to 60% of Tis(LAMN) [ 4 ]. These data suggest that KRAS mutations are important in tumor initiation but may be less critical for aggressive highgrade tumor progression. GNAS mutations, known as essential in abundant mucin production, are also presented in G1 and G2 tumors but less commonly in G3 tumors [ 31 - 35 ]. The co-mutation of GNAS and KRAS is identified in between 65% to 85% of cases [ 35 , 36 ]. Other minor mutations, including MET, PIK3CA, FAT4, AKT1, SMAD2, JAK3, STK11 , and RB1 have been identified [ 33 , 37 ]. However, BRAF mutation, microsatellite instability (MSI), and DNA mismatch repair protein deficiency are rarely seen in LAMN [ 10 , 38 ].

Pseudomyxoma peritonei, the clinical term for disseminated peritoneal mucinous disease, is a syndrome and applies to a neoplastic condition characterized by the grossly persistent accumulation of mucinous ascites in the peritoneal cavity [ 12 ]. The expansion of mucin within the abdominal cavity results from mucus following the normal flow of peritoneal fluid, redistribution of the mucin, and neoplastic cells [ 23 ]. Based on clinicopathological and immunohistochemical data, most cases are due to the perforation of AMNs [ 12 , 23 , 24 , 39 , 40 ]. Occasionally, mucinous neoplasms from other organs, including the colon, pancreas, ovary, and urachus, may also present with clinical appearances [ 12 , 23 , 24 , 39 , 40 ]. Immunohistochemical stains of cytokeratin 20 and CDX2 may be helpful in the diagnosis of the appendiceal origin ( Supplementary Fig. S1 ). Clinically, abdominal discomfort, distention, intestinal obstruction, and often omental cake in which the omentum transforms into a firm mass can present within the intraabdominal cavity [ 4 , 9 , 41 - 43 ]. Given this, pseudomyxoma peritonei is a clinical term and used mainly by oncologists and radiologists; thus, it should not be used in histopathologic diagnosis [ 13 ]. The tendency of tumor cells from the appendix to produce abundant extracellular mucin shows slow infiltration into the peritoneum and underlying tissues with rare lymphovascular invasion relative to the overall tumor bulk [ 5 ]. Accurate diagnosis of AMNs and disseminated peritoneal mucinous disease is essential because management may include follow-up or radical treatment such as CRS-HIPEC [ 23 ]. Ronnett et al. [ 9 ] classified disseminated peritoneal mucinous disease into three prognostically relevant categories: disseminated peritoneal adenomucinosis (DPAM), peritoneal mucinous carcinomatosis (PMCA), and PMCA with signet-ring cells [ 44 ]. However, the classification by Ronnett et al. [ 44 ] was not well established, leading to conflicting results. Given recent updates on diagnostic terminology, DPAM and PMCA are no longer recommended in pathology reports. Asare et al. [ 45 ] found that histologic grade was an independent predictor of survival in 25,992 patients with appendiceal cancer. The PSOGI consensus panel has presented the diagnostic terminology for disseminated peritoneal mucinous disease: lowgrade mucinous carcinoma peritonei, high-grade mucinous carcinoma peritonei, and high-grade mucinous carcinoma peritonei with signet-ring cells are equivalent to the alternative terminology of DPAM, PMCA, and PMCA with signet-ring cells, respectively. The AJCC 8th Cancer Staging Manual has proposed terminologies accompanying grading based on the criteria of Misdraji et al. [ 13 , 46 , 47 ]. Misdraji [ 46 ] used the diagnostic terms directly from the appendiceal neoplasm into the peritoneum: LAMN (G1) with peritoneal involvement, mucinous adenocarcinoma moderately differentiated (G2), and mucinous adenocarcinoma poorly differentiated (G3). In addition, acellular mucin is classified separately. Davison et al. [ 4 ] determined that the three-tiered grading is the most important predictive factor of overall survival in patients with stage IV AMNs. Low-grade (G1, well-differentiated) mucinous carcinoma peritonei, synonymous with a LAMN with peritoneal involvement, is defined as a mucinous neoplasm of low-grade cytology involving the peritoneum without infiltrative invasion or desmoplasia. Perineural and lymphovascular invasions are not seen. Typically, the neoplastic epithelial component accounts for less than 20% of the total mucin component. Low-grade (G1, well-differentiated) mucinous carcinoma peritonei almost always arises from a LAMN, so the AJCC 8th Cancer Staging Manual and Misdraji [ 46 ] proposed the term of LAMN with peritoneal involvement [ 13 ]. High-grade (G2, moderately differentiated) mucinous carcinoma peritonei, a synonym of moderately differentiated mucinous adenocarcinoma, is defined as a disseminated peritoneal mucinous tumor by the presence of high-grade cytology in the absence of signet-ring cells. The high-grade cytology criteria correspond to moderately differentiated (G2) appendiceal mucinous adenocarcinoma or HAMN. These can demonstrate diffuse high-grade cytology or display a mixture of low- and high-grade cytology areas. The cytologic features may be heterogeneous with low-grade areas with high-grade cytology, and this heterogeneity needs generous sampling for histologic evaluation. Cribriform complex growth and infiltrating tubular structures associated with stromal desmoplasia can be seen. Davison et al. [ 4 ] defined the high tumor cellularity as > 20% of the mucinous component. High-grade mucinous carcinoma peritonei with signet-ring cells (G3 tumor) shows high-grade cytology and invasive tumors with a signet-ring cell component, equivalent to poorly differentiated mucinous adenocarcinoma. High-grade (G2 and G3) disseminated peritoneal mucinous disease can present destructive infiltrative invasion into the extra-appendiceal spread, peritoneum, or other organs, frequently associated with perineural and lymphovascular invasion. The microscopic findings of a disseminated peritoneal mucinous tumor are presented in Fig. 8 . The discordance grade may be presented between appendiceal and peritoneal tumors. The PSOGI consensus panel recommends that peritoneal grading should be used for staging purposes, as intraperitoneal grading is more likely to influence patient prognosis [ 3 ]. However, the CAP protocol advocates that more highgrade tumors between the appendix and peritoneum should be assigned to the tumor for staging. These diverse ideas can lead to diagnostic confusion and difficulty; thus, more advanced investigations concerning prognosis are required. Regarding the potential discrepancy between G2 and G3 tumors, Breadly and Carr [ 40 ] recommended that more than 10% of the signet-ring cell components should be identified in the diagnosis of G3 tumors. Because degenerating tumor cells or even histiocytes floating within mucin pools without destructive invasion may often exhibit signet-ring cell-like features ( Fig. 8D ). Sirintrapun et al. [ 48 ] reported that isolated signet cells within mucin pools are less prognostically significant than those found in invading tissue. We surveyed the best criterion of a focal lesion with signet-ring cells at the workshop, and the results are shown in Supplementary Data S2 . The pathologic grade is an independent prognostic factor in patients with stage IV mucinous appendiceal neoplasms. Patients with high-grade (G2 or G3) disseminated peritoneal mucinous tumors have significantly worse survival than patients with low-grade (G1) tumors. Therefore, for high-grade disseminated peritoneal mucinous tumors, systemic chemotherapy followed by the option of CRS-HIPEC is recommended according to the therapeutic response [ 4 , 45 , 49 - 52 ]. The ICD-O3 code is 8480/6 in secondary disseminated peritoneal mucinous disease regardless of the grading; however, ICD-O3 is 8480/3 in the primary or unknown origin of disseminated peritoneal disease [ 53 ]. The histologic grade, behavior codes, diagnostic terminologies, and criteria for acellular mucin and disseminated peritoneal mucinous disease are summarized in Table 4 . In addition, the checklist of standard data elements of the appendiceal epithelial tumors, including disseminated peritoneal mucinous disease, is presented in Table 5 .